A carregar...
Perlecan-targeted nanoparticles for drug delivery to triple-negative breast cancer
AIM: We previously developed two antibodies that bind to a cell surface protein, perlecan, overexpressed in triple-negative breast cancer (TNBC). The goal of this study was to investigate these antibodies as targeting ligands for nanoparticle-mediated drug delivery. METHODS: Paclitaxel-loaded poly(D...
Na minha lista:
| Publicado no: | Future Drug Discov |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Newlands Press Ltd
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6700713/ https://ncbi.nlm.nih.gov/pubmed/31448368 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4155/fdd-2019-0005 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|